Enfusion Other Stockholder Equity from 2010 to 2025
| ENFN Stock | USD 11.14 0.02 0.18% |
Other Stockholder Equity | First Reported 2010-12-31 | Previous Quarter 243.9 M | Current Value 256.1 M | Quarterly Volatility 178.5 M |
Check Enfusion financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Enfusion's main balance sheet or income statement drivers, such as Tax Provision of 3.6 M, Net Interest Income of 1.8 M or Depreciation And Amortization of 12.1 M, as well as many indicators such as Price To Sales Ratio of 4.47, Dividend Yield of 0.0034 or PTB Ratio of 13.6. Enfusion financial statements analysis is a perfect complement when working with Enfusion Valuation or Volatility modules.
Enfusion | Other Stockholder Equity |
Latest Enfusion's Other Stockholder Equity Growth Pattern
Below is the plot of the Other Stockholder Equity of Enfusion over the last few years. It is Enfusion's Other Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Enfusion's overall financial position and show how it may be relating to other accounts over time.
| Other Stockholder Equity | 10 Years Trend |
|
Other Stockholder Equity |
| Timeline |
Enfusion Other Stockholder Equity Regression Statistics
| Arithmetic Mean | (13,328,516) | |
| Coefficient Of Variation | (1,339) | |
| Mean Deviation | 158,070,416 | |
| Median | (117,783,000) | |
| Standard Deviation | 178,508,872 | |
| Sample Variance | 31865.4T | |
| Range | 489.5M | |
| R-Value | 0.75 | |
| Mean Square Error | 14791.5T | |
| R-Squared | 0.57 | |
| Significance | 0.0008 | |
| Slope | 28,227,033 | |
| Total Sum of Squares | 477981.3T |
Enfusion Other Stockholder Equity History
About Enfusion Financial Statements
Enfusion investors utilize fundamental indicators, such as Other Stockholder Equity, to predict how Enfusion Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Other Stockholder Equity | 243.9 M | 256.1 M |
Check out the analysis of Enfusion Correlation against competitors. To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enfusion. If investors know Enfusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enfusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.82) | Earnings Share 0.03 | Revenue Per Share | Quarterly Revenue Growth 0.139 | Return On Assets |
The market value of Enfusion is measured differently than its book value, which is the value of Enfusion that is recorded on the company's balance sheet. Investors also form their own opinion of Enfusion's value that differs from its market value or its book value, called intrinsic value, which is Enfusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enfusion's market value can be influenced by many factors that don't directly affect Enfusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enfusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enfusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enfusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.